烷基磷胆碱：一类新型的膜活性抗癌药物。 - Suppr

Suppr

超能文献

Alkylphosphocholines: a new class of membrane-active anticancer agents.

作者信息

Hilgard P, Klenner T, Stekar J, Unger C

机构信息

ASTA Medica AG, Frankfurt am Main.

出版信息

Cancer Chemother Pharmacol. 1993;32(2):90-5. doi: 10.1007/BF00685608.

DOI:10.1007/BF00685608

PMID:8485813

Abstract

摘要

相似文献

Alkylphosphocholines: a new class of membrane-active anticancer agents.

Cancer Chemother Pharmacol. 1993;32(2):90-5. doi: 10.1007/BF00685608.

The development of alkylphosphocholines as signal transduction inhibitors: experimental and clinical challenges.

J Cancer Res Clin Oncol. 1997;123(5):286-7. doi: 10.1007/BF01208640.

Induction of tumor cell differentiation by alkylphosphocholines: a new approach for in vitro screening.

Prog Exp Tumor Res. 1992;34:90-7. doi: 10.1159/000420835.

In vitro and in vivo antitumoral activity of alkylphosphonates.

Eur J Cancer. 1992;29A(1):96-101. doi: 10.1016/0959-8049(93)90583-2.

Hexadecylphosphocholine: a new and selective antitumor drug.

Cancer Treat Rev. 1990 Sep;17(2-3):233-42. doi: 10.1016/0305-7372(90)90053-i.

Antineoplastic activity in vitro of free and liposomal alkylphosphocholines.

Anticancer Drugs. 1993 Feb;4(1):57-64. doi: 10.1097/00001813-199302000-00008.

Efficacy of anticancer alkylphosphocholines in Trypanosoma brucei subspecies.

Acta Trop. 1997 Apr 15;64(3-4):145-54. doi: 10.1016/s0001-706x(96)00628-6.

Antineoplastic activity of alkylphosphocholines (APC) in human breast carcinomas in vivo and in vitro; use of liposomes.

Breast Cancer Res Treat. 1994;32(3):269-79. doi: 10.1007/BF00666004.

Systemic administration of alkylphosphocholines. Erucylphosphocholine and liposomal hexadecylphosphocholine.

Adv Exp Med Biol. 1996;416:165-8.

Tumor heterogeneity and chemosensitivity to cyclophosphamide, vinblastine and hexadecylphosphocholine.

Cancer Treat Rev. 1990 Sep;17(2-3):339-45. doi: 10.1016/0305-7372(90)90067-p.

引用本文的文献

Enlightening the invisible: Applications, limits and perspectives of intraoperative fluorescence in neurosurgery.

Brain Spine. 2024 Oct 10;4:103928. doi: 10.1016/j.bas.2024.103928. eCollection 2024.

Nanotechnological approaches in the treatment of schistosomiasis: an overview.

Beilstein J Nanotechnol. 2024 Jan 3;15:13-25. doi: 10.3762/bjnano.15.2. eCollection 2024.

Activation of Investigator-Initiated Clinical Trials with a Pharmaceutical for Cancer Patients before and after Post-Millennial Changes of Regulations in Germany and Europe.

Cancers (Basel). 2022 Mar 3;14(5):1308. doi: 10.3390/cancers14051308.

Measuring Critical Micelle Concentration as a Function of Cavitand Additives Using Surface Tension and Dye Micellization.

Ronald E McNair Postbac Achiev Program. 2010;14:155-168.

Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens.

PLoS Negl Trop Dis. 2017 Aug 25;11(8):e0005853. doi: 10.1371/journal.pntd.0005853. eCollection 2017 Aug.

Evaluation of the effect of miltefosine on Trichomonas vaginalis.

Parasitol Res. 2014 Mar;113(3):1041-7. doi: 10.1007/s00436-013-3738-z. Epub 2013 Dec 22.

Erufosine suppresses breast cancer in vitro and in vivo for its activity on PI3K, c-Raf and Akt proteins.

J Cancer Res Clin Oncol. 2012 Nov;138(11):1909-17. doi: 10.1007/s00432-012-1271-6. Epub 2012 Jun 30.

Perifosine , an oral, anti-cancer agent and inhibitor of the Akt pathway: mechanistic actions, pharmacodynamics, pharmacokinetics, and clinical activity.

Expert Opin Drug Metab Toxicol. 2012 May;8(5):623-33. doi: 10.1517/17425255.2012.681376.

Lysolipid containing liposomes for transendothelial drug delivery.

BMC Res Notes. 2012 Apr 10;5:179. doi: 10.1186/1756-0500-5-179.

Potential involvement of F0F1-ATP(synth)ase and reactive oxygen species in apoptosis induction by the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines : a mechanism for induction of apoptosis via the 18 kDa mitochondrial translocator protein.

Apoptosis. 2010 Jul;15(7):753-68. doi: 10.1007/s10495-010-0460-5.

本文引用的文献

Tumor cytotoxicity of human macrophages after incubation with synthetic analogues of 2-lysophosphatidylcholine.

J Natl Cancer Inst. 1984 Jan;72(1):53-9. doi: 10.1093/jnci/72.1.53.

Alkyl phosphocholines: toxicity and anticancer properties.

Lipids. 1987 Nov;22(11):930-4. doi: 10.1007/BF02535558.

Metabolism of ether phospholipids and analogs in neoplastic cells.

Lipids. 1987 Nov;22(11):856-61. doi: 10.1007/BF02535544.

Enhancement of the antiproliferative effect of cis-diamminedichloroplatinum(II) and nitrogen mustard by inhibitors of protein kinase C.

Int J Cancer. 1988 Sep 15;42(3):382-8. doi: 10.1002/ijc.2910420313.

Characterization of the antitumor activity of hexadecylphosphocholine (D 18506).

Eur J Cancer Clin Oncol. 1988 Sep;24(9):1457-61. doi: 10.1016/0277-5379(88)90336-7.

Specific interaction between phosphatidylinositol 4,5-bisphosphate and profilactin.

Nature. 1985;314(6010):472-4. doi: 10.1038/314472a0.

Synergistic enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by the ether lipid analogue BM41440, an inhibitor of protein kinase C.

Lipids. 1989 Apr;24(4):312-7. doi: 10.1007/BF02535169.

The specific inhibitor of protein kinase C, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H7), induces morphological change and cell differentiation of human neural crest-derived cell lineages.

FEBS Lett. 1990 Aug 20;269(1):4-6. doi: 10.1016/0014-5793(90)81104-v.

In vitro investigations on the antineoplastic effect of hexadecylphosphocholine.

Arzneimittelforschung. 1991 Jun;41(6):652-5.

Hexadecylphosphocholine-mediated enhancement of T-cell responses to interleukin 2.

Cell Immunol. 1991 Oct 1;137(1):232-8. doi: 10.1016/0008-8749(91)90072-j.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验